Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan flag Jordan · Delayed Price · Currency is JOD
1.550
-0.040 (-2.52%)
At close: Mar 18, 2026

ASE:PHIL Cash Flow Statement

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1.010.820.810.70.41
Depreciation & Amortization
0.530.280.290.120.16
Other Amortization
-0.30.30.250.1
Loss (Gain) From Sale of Assets
-0.03-0.01---
Provision & Write-off of Bad Debts
----0.01
Other Operating Activities
0.420.360.370.270.57
Change in Accounts Receivable
-0.150.07-0.20.461.94
Change in Inventory
-0.37-0.01-0.480.250.46
Change in Accounts Payable
0.11-0.130.220.04-0.14
Change in Other Net Operating Assets
-0.150.04-0.210.02-0.37
Operating Cash Flow
1.371.721.12.113.15
Operating Cash Flow Growth
-20.31%56.55%-47.82%-33.02%84.84%
Capital Expenditures
-0.22-0.19-0.07-0.17-0.2
Sale of Property, Plant & Equipment
0.060.03-0.030.04
Sale (Purchase) of Intangibles
---0.01-1.82-2.49
Sale (Purchase) of Real Estate
--0.92---
Investing Cash Flow
-0.16-1.08-0.07-1.96-2.66
Short-Term Debt Issued
---0.38-
Long-Term Debt Issued
-1.31---
Total Debt Issued
-1.31-0.38-
Short-Term Debt Repaid
-0.16-0.82-0.34--0.19
Long-Term Debt Repaid
-0.07----
Total Debt Repaid
-0.23-0.82-0.34--0.19
Net Debt Issued (Repaid)
-0.230.49-0.340.38-0.19
Common Dividends Paid
-0.53-0.53-0.45-0.45-
Other Financing Activities
-0.29-0.35-0.34-0.24-0.23
Financing Cash Flow
-1.04-0.38-1.12-0.31-0.43
Net Cash Flow
0.170.25-0.1-0.160.06
Free Cash Flow
1.151.531.031.942.94
Free Cash Flow Growth
-24.44%47.69%-46.74%-34.02%88.22%
Free Cash Flow Margin
12.58%17.43%12.30%23.07%44.57%
Free Cash Flow Per Share
0.150.200.140.260.39
Cash Interest Paid
----0.23
Cash Income Tax Paid
-0.220.180.130.02
Levered Free Cash Flow
0.671.010.52-0.28-0.16
Unlevered Free Cash Flow
0.851.240.73-0.13-0.02
Change in Working Capital
-0.56-0.02-0.670.771.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.